Nisa Investment Advisors
GYRE icon

Nisa Investment Advisors’s Gyre Therapeutics GYRE Stock Holding History

Nisa Investment Advisors’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$711 Hold
102
– – ﹤0.01% 2807
2025
Q4 		$720 Hold
102
– – ﹤0.01% 2765
2025
Q3 		$761 Buy
102
+43
+73% +$326 ﹤0.01% 2788
2025
Q2 		$434 Sell
59
-2
-3% -$17 ﹤0.01% 2894
2025
Q1 		$471 Sell
61
-23
-27% -$252 ﹤0.01% 2811
2024
Q4 		$1.02K Hold
84
– – ﹤0.01% 2677
2024
Q3 		$1.05K Buy
+84
New +$1.08K ﹤0.01% 2564

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nisa Investment Advisors's GYRE Position: Q1 2026 in Review

Nisa Investment Advisors held its Gyre Therapeutics (GYRE) position steady in Q1 2026 at 102 shares worth $711. The position accounts for ﹤0.01% of the portfolio, ranked #2807.

Nisa Investment Advisors first reported a position in GYRE in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.05K in Q3 2024. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

  • Nisa Investment Advisors held 102 shares of Gyre Therapeutics worth $711 as of Q1 2026.
  • Nisa Investment Advisors left its Gyre Therapeutics share count unchanged in Q1 2026.
  • Gyre Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2807 holding.
  • Nisa Investment Advisors first reported a position in Gyre Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Nisa Investment Advisors's Gyre Therapeutics position peaked at $1.05K in Q3 2024.
  • 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.